Cryosite, the highest standard of cord blood and tissue banking in Australia

Cryosite has been banking cord blood stem cells since 2002 and are fully licensed by the Therapeutic Goods Administration (TGA), and accredited by NATA, to provide both autologous and directed allogeneic cord blood stem cell banking services.
Expert Industry Knowledge and Onsite Research

Our team of leading scientists have also developed an effective method to extract and store viable mesenchymal stem cells (MSCs) from umbilical cord tissue. These stem cells are being studied for potentially groundbreaking future applications in bone, cartilage, tendon and neuron regeneration.

Saving both cord blood and cord tissue stem cells gives your family the opportunity to access current and future therapies.

Tissue banking methods unique to Cryosite

- Cryosite provides parents with more tissue banking options. We extract the high value MSC’s from the perivascular region of the umbilical cord prior to storage to maintain their viability AND also store the remaining cord tissue in case a valid method is developed in the future to use these residual cells.
- Cryosite do not charge additional fees to store using BOTH methods.
- We are the only company with patent protected access to the unique stem cell source the highly concentrated perivascular region of the umbilical cord.
- Cryosite’s utilises validated patented cord tissue methods.
- Cryosite’s methods are accepted and protected under the following Australian patents:
1. Progenitor Cells from WJ of Human Umbilical Cord {Patent ref: AU 2004210891}
2. Viable Cells from Frozen Umbilical Cord Tissue {Patent ref: AU 2006329195}
3. Immune Privileged and Modulatory Progenitor Cells {Patent ref: AU 2007247725}